drugset / Trial / NCT02226601

Aprepitant to Mitigate Opioids' Cognitive Side Effects

NCT02226601

Unknown 50 enrolled University of Arizona
RandomizedParallel-groupTriple-blindTreatment

Summary

Morphine and similar substances (called opioids) are often prescribed for moderate to severe pain, such as after a surgery, thus allowing for minimal pain and a better recovery. Unfortunately various, non-dangerous side effects from opioids occur often that limit the way patients feel and can take of themselves, despite otherwise good pain control and minimal limitations from the surgery itself.

Timeline

Start
2014-10
Primary completion
2016-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aprepitant Other / unclassified 40 mg Intravenous

Indications